Hisun Pharma's Anriketfen Injection New Indications Approved

Wisdom Finance APP news: Hisun Pharma (002653.SZ) announced that the company recently received a "Drug Registration Certificate" for the 1st class innovative drug anruifen injection (trade name: Sishujing, research and development code: HSK21542) issued by the National Medical Products Administration. The new indication added this time is "treatment of moderate to severe pruritus related to chronic kidney disease in adult maintenance hemodialysis patients".